20 April 2004
Gemcitabine induced pulmonary injury
Ugur Coskun , Nazan Gunel , Yesim YildirimCase Rep Clin Pract Rev 2004; 5(null):178-179 :: ID: 12264
Abstract
Background: Many cytotoxic drugs can cause pulmonary injury in different degrees. Fatal pulmonary injury due to gemcitabine therapy was reported in literature only in three cases.Case Report: Massive pulmonary hemorrhage in patient with pancreas cancer after first use of gemcitabine is presented. The patients died of pulmonary insufficiency 6 days after the first gemcitabine dministrationConclusions: Patients receiving gemcitabine treatment should be followed-up carefully for this fatal pulmonary toxicity.
Keywords: Gemcitabine, pulmonary injury, pancreas carcinoma
437
In Press
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.949976
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950290
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950607
Case report
Am J Case Rep In Press; DOI: 10.12659/AJCR.950985
Most Viewed Current Articles
07 Dec 2021 : Case report
17,691,734
DOI :10.12659/AJCR.934347
Am J Case Rep 2021; 22:e934347
06 Dec 2021 : Case report
164,491
DOI :10.12659/AJCR.934406
Am J Case Rep 2021; 22:e934406
21 Jun 2024 : Case report
113,090
DOI :10.12659/AJCR.944371
Am J Case Rep 2024; 25:e944371
07 Mar 2024 : Case report
59,175
DOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133






